3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
6
Rectal Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Colonic Neoplasms
5
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, Follicular
4
Immunoblastic Lymphadenopathy
4
Colorectal Neoplasms
4
Carcinoma, Renal Cell
4
Breast Neoplasms, Male
4
Sezary Syndrome
3
Pancreatic Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Mantle-Cell
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma
3
Esophageal Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Waldenstrom Macroglobulinemia
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
Cetuximab
4
Radiosurgery
3
Nivolumab
3
Ipilimumab
3
pembrolizumab
2
Vorinostat
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Magnetic Resonance Spectroscopy
2
Lapatinib
2
Dasatinib
2
Cisplatin
2
CTLA-4 Antigen
2
Bevacizumab
2
temsirolimus
1
ispinesib
1
eribulin
1
dehydroftorafur
1
apalutamide
1
amivantamab
1
alectinib
1
Specimen Handling
1
Sorafenib
1
Sirolimus
1
Platinum
1
Pilocarpine
1
Pemetrexed
1
Oral Hygiene
1
NVP-BKM120
1
Moxibustion
1
MK 2206
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Salivary Gland Neoplasms
×
Immunohistochemistry
×
Clear all
No trials found.